Home
Home » companies

Rigel Pharmaceuticals

3 Drug Catalysts to Watch in 2013

3 Drug Catalysts to Watch in 2013
Motley Fool

Rigel Pharmaceuticals Becomes Oversold (RIGL)

Rigel Pharmaceuticals Becomes Oversold (RIGL)
The Street

[video]3 Biggest Biotech Crashes in April

[video]3 Biggest Biotech Crashes in April
Motley Fool

This Week in Biotech

This Week in Biotech
Motley Fool

3 Horrendous Health-Care Stocks This Week

3 Horrendous Health-Care Stocks This Week
Motley Fool

Rigel Pharmaceuticals: 7 Reasons To Buy This $7 Drug Stock

Rigel Pharmaceuticals: 7 Reasons To Buy This $7 Drug Stock
Seeking Alpha

JPMorgan Healthcare Conference Rewind: Rigel Pharmaceuticals

JPMorgan Healthcare Conference Rewind: Rigel Pharmaceuticals
Motley Fool

AstraZeneca's RA Drug Disappoints

AstraZeneca's RA Drug Disappoints
Yahoo/Zacks

Bag Rigel Pharmaceuticals Even Cheaper Than Its Secondary?

Bag Rigel Pharmaceuticals Even Cheaper Than Its Secondary?
Forbes

Rigel Pharma prices public offering of stock at $9.50 per share, shares tumble on news

Rigel Pharma prices public offering of stock at $9.50 per share, shares tumble on news
Yahoo/AP